That comes from a different trial: the Phase 1 single-dose study in lean participants, where -hydroxybutyrate started below the assays detection floor and reached 708 mol/L at 4.5 mg by day 8 a large, dose-ordered rise in a lean cohort. The MASLD substudy, by contrast, found ketones moving only at 4 mg and above in a group with insulin resistance damping the readout
Yes, you can stop at any time
Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial
Schutz vor UV-Schden: GHK-Cu mildert die schdlichen Auswirkungen der UV-Strahlung auf die Haut
Both BPC-157 and TB500 are of interest in preclinical research for their potential to support recovery from injuries affecting muscles, ligaments, and other connective tissues